Bibliothek

Sprache
Bevorzugter Suchindex
Ergebnisse pro Seite
Sortieren nach
Sortierung
Anzahl gespeicherter Suchen in der Suchhistorie
E-Mail-Adresse
Voreingestelltes Exportformat
Voreingestellte Zeichencodierung für Export
Anordnung der Filter
Maximale Anzahl angezeigter Filter
Autovervollständigung
Feed-Format
Anzahl der Ergebnisse pro Feed
feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    ISSN: 1432-0428
    Schlagwort(e): Type 2 (non-insulin-dependent) diabetes mellitus ; end-stage renal disease ; dialysis ; neuropathy ; mortality ; Japan ; chronic glomerulonephritis ; vasculopathy
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Summary According to a national survey of dialysis patients in Japan conducted by the Japanese Society for Dialysis Therapy, there were 1,033 patients on dialysis in the Shiga area which has a population of about 1.2 million. Of these 1,033 dialysis patients 140 were the result of diabetic nephropathy. From four hospitals affiliated to Shiga University of Medical Science the medical records of 90 diabetic subjects on dialysis therapy were reviewed and various clinical parameters were analysed and compared with those of patients with chronic glomerulonephritis. Since only one patient had Type 1 (insulin-dependent) diabetes, the remaining 89 with Type 2 (non-insulin-dependent) diabetes were used for this study. The significantly different variables between patients with Type 2 diabetes and chronic glomerulonephritis were age (60.4 vs 54.6 years,p〈0.05), BMI (22.4 vs 20.6 kg/m2,p〈0.001), cardiothoracic ratio (56.4 vs 53.3%,p〈0.001), mean blood pressure (110 vs 117 mm Hg,p〈0.05), serum creatinine (9.0 vs 11.5 mg/dl,p〈0.001), serum urea-N (98.2 vs 115.5 mg/dl,p〈0.001), serum total protein (6.0 vs 6.5 g/dl,p〈0.001) and serum albumin (3.5 vs. 3.9 g/dl,p〈0.001). Serum levels of cholesterol and triglyceride were not significantly different between two groups, though the prevalence of electrocardiogram abnormalities, oedema, neuropathy, myocardial infarction and cerebrovascular diseases was significantly higher in the Type 2 diabetic group. These results suggested that Type 2 diabetic patients with end-stage renal disease were older, more malnurished, fluid overloaded and multi-morbid as a result of vasculopathy and neuropathy. However, the analysis of causes of death in Type 2 diabetic patients (n=24) and patients with chronic glomerulonephritis (n=26) failed to provide evidence of higher risk of cardiac death in the Type 2 diabetic group compared to the group with chronic glomerulonephritis (37.5 vs 34.6%, NS). In the Type 2 diabetic patients on dialysis therapy, malnutrition, fluid overload and neuropathy appeared to be significant factors influencing the outcome of the therapy, while in patients with chronic glomerulonephritis, age and vascular morbidities were considered to be major risk factors for the prognosis.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    ISSN: 1569-8041
    Schlagwort(e): chemotherapy ; HBV carrier ; hepatitis B ; malignant lymphoma
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Abstract Background: Hepatitis B after the withdrawal of cytotoxicchemotherapy in hepatitis B virus (HBV) carriers is well known and may leadto fatal hepatic failure. We retrospectively analyzed the prevalence of HBVcarriers, the incidence, and the risk factors of hepatitis B in the treatmentof malignant lymphoma. Patients and methods: HBV carriers were defined as patients withpositive HBs-antigen, either with normal or abnormal serum aminotransferaselevel at patient presentation. Questionnaires to the members of the JapanLymphoma Treatment Study Group included general information, details about HBVcarriers, and further information about hepatitis B. Results: Among 1380 patients collected from eight institutions, 45patients (3.26%) were determined to be HBV carriers. Hepatitis Bdeveloped in 17 of the HBV carrying patients (37.8%). Seven of those17 (41.2%) died of hepatic failure. Hepatitis developed at a high ratein patients who were negative for HBe-antigen (50%), and who hadreceived second- or third-generation chemotherapy (63.2%). Conclusion: We confirmed that hepatitis B developed with highfrequency in HBV carriers with malignant lymphoma. Moreover, hepatitis oftenresulted in fatal hepatic failure. It is necessary to prevent the hepatitisB developing in HBV carriers when receiving intensive chemotherapy formalignant lymphoma.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...